251.51MMarket Cap-2.06P/E (TTM)
3.942High3.370Low1.15MVolume3.850Open3.840Pre Close4.19MTurnover2.59%Turnover RatioLossP/E (Static)70.65MShares7.20052wk High1.51P/B158.86MFloat Cap1.12052wk Low--Dividend TTM44.62MShs Float53.460Historical High--Div YieldTTM14.90%Amplitude0.891Historical Low3.625Avg Price1Lot Size
Personalis Stock Forum
Personalis and Tempus Expand Collaboration to Biopharma
Monday, 16th December at 8:00 am
Expanded collaboration to yield greater biopharma access to Personalis' MRD solution
Personalis, Inc. (NASDAQ: PSNL) and Tempus AI, Inc. (NASDAQ: TEM) announced today that the companies have expanded their commercial relationship. The companies agreed in November 2023 to collaborate and bring ultra-sensitive MRD testing to market and launched their efforts at the 2024 American Soc...
📊⚡️📊
In a world where technological advancements continually reshape the landscape of healthcare, collaboration among industry leaders plays a pivotal role in accelerating innovation. A testament to this is the expanded collaboration between Personalis, Inc., a renowned leader in cancer genomics, and Tempus AI, Inc., a technology-driv...
📊⚡️📊
📊⚡️📊
Support Level @ $1.62, established from the recent low prior to the breakout.
Resistance Level@ $5.273, derived from projections based on the stock's momentum and the recent news's impact.
No comment yet